PMDA drug package insert
ヘモナーゼ配合錠
PMDA Prescription drug · ジェイドルフ製薬株式会社 · package insert Jan 31, 2025
Key facts
| Brand names | ヘモナーゼ配合錠 |
|---|---|
| Nonproprietary names | ブロメライン・トコフェロール酢酸エステル |
| Companies | 製造販売元／ジェイドルフ製薬株式会社, 販売元／堀井薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 痔疾治療剤 |
| Therapeutic category codes | 872559 |
| YJ codes | 2559101X1036 |
| Approval numbers | 22000AMX01456 |
| Package insert edition | 第3版 |
| Package insert date | Jan 31, 2025 |
| PMDA document key | 340269_2559101X1036_2 |
| PMDA company code | 340269 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: